Integragen (PA:ALINT) — Stock Price
Integragen (PA:ALINT) is currently trading at €0.16 EUR, down 0.90% today. Over the past 52 weeks, shares have ranged between €0.13 and €0.36. This page tracks Integragen's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Integragen market capitalisation.
Integragen (ALINT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Integragen's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Integragen Income Statement — Revenue, Profit & Earnings by Year
Integragen's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €8.70 Million | €12.54 Million | €13.17 Million | €11.32 Million | €8.98 Million |
| Cost of Revenue | €6.91 Million | €12.54 Million | €13.17 Million | €11.28 Million | €9.07 Million |
| Gross Profit | €1.79 Million | €-6.98K | €-6.36K | €43.69K | €-89.45K |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | €4.56 Million | €3.91 Million |
| Total Operating Expenses | €2.93 Million | €5.35 Million | €5.52 Million | €73.25K | €3.69 Million |
| Operating Income | €-807.00K | €-183.76K | €-139.12K | €-29.55K | €-254.14K |
| EBITDA | €-296.00K | €-52.50K | €69.96K | €96.45K | €-235.89K |
| EBIT | €-353.00K | €-250.71K | €-131.59K | €-109.44K | €-462.24K |
| Interest Expense | €4.86K | €8.37K | €11.92K | €4.88K | €5.21K |
| Income Before Tax | €-352.00K | €-259.08K | €-143.52K | €-114.32K | €-467.45K |
| Income Tax Expense | €-96.00K | €-87.68K | €-140.01K | €-129.73K | €-92.42K |
| Net Income | €-256.00K | €-171.40K | €-3.51K | €15.41K | €-375.02K |
Integragen Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Integragen's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €5.51 Million | €8.00 Million | €9.02 Million | €9.60 Million | €8.82 Million |
| Total Current Assets | €5.26 Million | €7.68 Million | €8.56 Million | €8.97 Million | €7.95 Million |
| Cash & Equivalents | — | — | — | €1.84 Million | €4.11 Million |
| Short-term Investments | €1.05 Million | €1.04 Million | €2.05 Million | €1.84 Million | €4.11 Million |
| Net Receivables | €3.16 Million | €4.30 Million | €3.49 Million | €3.67 Million | €2.40 Million |
| Inventory | €205.00K | €311.45K | €396.93K | €342.58K | €237.88K |
| Property, Plant & Equipment | — | — | — | €624.00K | €572.00K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €3.76 Million | €5.99 Million | €6.82 Million | €7.42 Million | €6.65 Million |
| Total Current Liabilities | €1.94 Million | €5.18 Million | €5.61 Million | €5.35 Million | €3.93 Million |
| Long-term Debt | — | €642.28K | €1.16 Million | €1.95 Million | €2.02 Million |
| Net Debt | €-1.26 Million | €-709.75K | €-787.65K | €-983.73K | €996.28K |
| Total Stockholder Equity | €1.75 Million | €2.01 Million | €2.20 Million | €2.19 Million | €2.17 Million |
| Retained Earnings | €-1.61 Million | €-1.35 Million | €-1.18 Million | €-1.18 Million | €-9.64 Million |
Integragen Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Integragen generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Operating Cash Flow | €403.11K | €411.78K | €452.69K | €256.10K | €135.90K |
| Capital Expenditures | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Free Cash Flow | €403.11K | €411.78K | €452.69K | €256.10K | €135.90K |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €201.56K | €205.89K | €226.34K | €256.10K | €135.90K |
| Change in Cash | €-476.77K | €1.92 Million | €-179.85K | €464.00K | €-607.55K |
Integragen Earnings History — EPS Actual vs. Analyst Estimates
Track Integragen's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 30, 2025 | 0.00 | 0.00 | — |
| Apr 29, 2025 | 0.00 | 0.00 | — |
| Jul 30, 2024 | -0.02 | 0.00 | — |
| Apr 24, 2023 | 0.02 | 0.00 | — |
| Oct 18, 2022 | -0.02 | — | — |
| Apr 29, 2022 | 0.07 | 0.00 | — |
| Oct 08, 2021 | -0.06 | 0.00 | — |
| Apr 19, 2021 | -0.06 | 0.00 | — |